Image Description (Desvenlafaxine Tablets Figure 1)
Desvenlafaxine Tablet, Extended Release
Product Images NDC 50090-7737
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 50090-7737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Desvenlafaxine Tablets Figure 2)
This is a comparison of the change in Cmax levels of Ketoconazole due to PK with CYP3A4 inhibitors. The geometric mean ratios with 90% confidence intervals are provided for the change relative to the reference values. For Ketoconazole Cmax, the values are 1.08 (1.00-1.17) and 1.43 (1.38-1.49).*
Image Description (Desvenlafaxine Tablets Figure 3)
Image Description (Desvenlafaxine Tablets Figure 4)
This is a chart showing the estimated proportion of patients with relapse over time to relapse in days from randomization for a treatment with Desverla 50mg compared to a placebo. The chart indicates that by day 200, around 40% of patients on Desverla 50mg and 0% of patients on placebo had experienced a relapse.*
Image Description (Desvenlafaxine Tablets Figure 5)
Image Description (Desvenlafaxine Tablets Structure)
Label Image (Lbl500907737)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
